Contact Us
Language
About GHG
Academic Achievements
GHG News
Expert Insights
Medical Centers
Beijing GoBroad Hospital
Beijing GoBroad Boren Hospital
Shanghai GoBroad Cancer Hospital
GoBroad Medical Institute of Hematology (Shanghai Center)
Nanfang-Chunfu Children's Institute of Hematology
Patient Center
Hematologic Diseases Treatment
Solid Tumor Treatment
Specialized Services
Patient Stories
Patient Guide
Frequently Asked Questions
About GHG
Academic Achievements
GHG News
Expert Insights
Medical Centers
Beijing GoBroad Hospital
Beijing GoBroad Boren Hospital
Shanghai GoBroad Cancer Hospital
GoBroad Medical Institute of Hematology (Shanghai Center)
Nanfang-Chunfu Children's Institute of Hematology
Patient Center
Hematologic Diseases Treatment
Solid Tumor Treatment
Specialized Services
Patient Stories
Patient Guide
Frequently Asked Questions
About GHG
Academic Achievements
GHG News
Expert Insights
Medical Centers
Beijing GoBroad Hospital
Beijing GoBroad Boren Hospital
Shanghai GoBroad Cancer Hospital
GoBroad Medical Institute of Hematology (Shanghai Center)
Nanfang-Chunfu Children's Institute of Hematology
Patient Center
Hematologic Diseases Treatment
Solid Tumor Treatment
Specialized Services
Patient Stories
Patient Guide
Frequently Asked Questions
About GHG
Academic Achievements
GHG News
Expert Insights
Medical Centers
Beijing GoBroad Hospital
Beijing GoBroad Boren Hospital
Shanghai GoBroad Cancer Hospital
GoBroad Medical Institute of Hematology (Shanghai Center)
Nanfang-Chunfu Children's Institute of Hematology
Patient Center
Hematologic Diseases Treatment
Solid Tumor Treatment
Specialized Services
Patient Stories
Patient Guide
Frequently Asked Questions
中文
English
Pусский
العربية
GHG News
Chicago 2025 China Summit Successfully Concludes: Chinese Research Shines on ASCO Stage, Resonating with the Global Oncology Community
2025-6-6
View
GHG Medical Team to Present Three Innovative Studies at ASCO 2025
2025-5-22
View
EHA 2025 | GoBroad Medical Team Presents 24 Research Achievements on the Global Stage! Multi-Dimensional Innovations Break Therapeutic Boundaries and Enhance Patient Survival
2025-5-15
View
Pioneering the introduction of groundbreaking medications, offering renewed hope to patients with relapse or refractory tumors.
2025-3-4
View
Breaking Through Drug Resistance! Beijing GoBroad Hospital has Issued the First Prescription for Taletrectinib in Beijing, Bringing Renewed Hope for Advanced Lung Cancer Patients
2025-2-22
View
China Pharmaceutical University and GoBroad Healthcare Group Establish the "Institute of Statistical Science" to Advance Biopharmaceutical Research and Clinical Innovation
2025-2-13
View
The "Beijing Key Laboratory of Cell and Gene Therapy for Solid Tumors" headed by Prof. Shen Lin was successfully approved.
2025-2-7
View
Successfully Passed the Review! Beijing GoBroad Hospital Has Obtained the Qualification for Clinical Application of Lu-177 Radionuclide Therapy
2024-12-10
View
ASH2024丨17 achievements of GoBroad medical team highlight the international academic stage!
2024-11-1
View
1
2
3
Remote Second Opinion